Although AChE is the predominant enzyme under physiological conditions, butyrylcholinesterase (BChE) assumes a compensatory function as AD advances, making dual inhibition of both enzymes a more comprehensive and clinically relevant strategy. Here, ACHE is linked to Alzheimer disease.